Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development

Signal Transduct Target Ther. 2020 Jul 13;5(1):125. doi: 10.1038/s41392-020-00233-4.

Abstract

Stress proteins (SPs) including heat-shock proteins (HSPs), RNA chaperones, and ER associated stress proteins are molecular chaperones essential for cellular homeostasis. The major functions of HSPs include chaperoning misfolded or unfolded polypeptides, protecting cells from toxic stress, and presenting immune and inflammatory cytokines. Regarded as a double-edged sword, HSPs also cooperate with numerous viruses and cancer cells to promote their survival. RNA chaperones are a group of heterogeneous nuclear ribonucleoproteins (hnRNPs), which are essential factors for manipulating both the functions and metabolisms of pre-mRNAs/hnRNAs transcribed by RNA polymerase II. hnRNPs involve in a large number of cellular processes, including chromatin remodelling, transcription regulation, RNP assembly and stabilization, RNA export, virus replication, histone-like nucleoid structuring, and even intracellular immunity. Dysregulation of stress proteins is associated with many human diseases including human cancer, cardiovascular diseases, neurodegenerative diseases (e.g., Parkinson's diseases, Alzheimer disease), stroke and infectious diseases. In this review, we summarized the biologic function of stress proteins, and current progress on their mechanisms related to virus reproduction and diseases caused by virus infections. As SPs also attract a great interest as potential antiviral targets (e.g., COVID-19), we also discuss the present progress and challenges in this area of HSP-based drug development, as well as with compounds already under clinical evaluation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / pharmacology*
  • Betacoronavirus / drug effects*
  • Betacoronavirus / genetics
  • Betacoronavirus / pathogenicity
  • COVID-19
  • Chromatin Assembly and Disassembly / drug effects
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / genetics
  • Coronavirus Infections / pathology
  • Coronavirus Infections / virology
  • Gene Expression Regulation
  • Heat-Shock Proteins / agonists
  • Heat-Shock Proteins / antagonists & inhibitors
  • Heat-Shock Proteins / genetics*
  • Heat-Shock Proteins / metabolism
  • Heterogeneous-Nuclear Ribonucleoproteins / agonists
  • Heterogeneous-Nuclear Ribonucleoproteins / antagonists & inhibitors
  • Heterogeneous-Nuclear Ribonucleoproteins / genetics*
  • Heterogeneous-Nuclear Ribonucleoproteins / metabolism
  • Host-Pathogen Interactions / drug effects*
  • Host-Pathogen Interactions / genetics
  • Humans
  • Molecular Targeted Therapy / methods
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / genetics
  • Pneumonia, Viral / pathology
  • Pneumonia, Viral / virology
  • RNA Polymerase II / genetics
  • RNA Polymerase II / metabolism
  • RNA Precursors / genetics
  • RNA Precursors / metabolism
  • SARS-CoV-2
  • Severity of Illness Index
  • Signal Transduction
  • Transcription, Genetic / drug effects
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Heat-Shock Proteins
  • Heterogeneous-Nuclear Ribonucleoproteins
  • RNA Precursors
  • RNA Polymerase II